
Keywords: AF, atrial fibrillation; CVE, cardiovascular event; HF, heart failure; HR, hazard ratio; MetS, metabolic syndrome; MI, myocardial infarction; NOAC, non-vitamin K antagonist oral anticoagulant; TIA, transient ischemic attack; VKA, vitamin K antagonist